Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Serum protein fingerprinting.

Timothy D Veenstra¹, Thomas P Conrads

¹SAIC-Frederick Inc, National Cancer Institute at Frederick, PO Box B, Frederick, MD 21702-1201, USA.

Current Opinion in Molecular Therapeutics

|February 6, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ATR kinase inhibitors induce mitochondrial fission in CD8<sup>+</sup> T cells and impair immune memory <i>in vivo</i>.

bioRxiv : the preprint server for biology·2026

Same author

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Nature communications·2026

Same author

Laser capture microdissection.

Nature reviews. Methods primers·2026

Same author

Immunoproteomic insights into inflammatory diseases of the critically endangered black rhinoceros (Diceros bicornis).

Scientific reports·2026

Same author

Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.

Cells·2026

Same author

Progestin and vitamin D synergistically inhibit fallopian tube carcinogenesis.

Gynecologic oncology·2026

Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011

Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010

Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010

Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010

Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010

Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010

See all related articles

Proteomic pattern analysis uses mass spectrometry to detect disease biomarkers. This technology enables rapid, sensitive, and predictive clinical diagnostics for improved patient outcomes.

Area of Science:

Biochemistry
Biotechnology
Clinical Diagnostics

Background:

Proteomics technologies enable global protein expression measurements.
Novel biomarkers are sought for clinical medicine advancements.
Proteomic pattern analysis is a novel application of mass spectrometry.

Purpose of the Study:

To highlight the potential of proteomic pattern analysis for early disease diagnosis.
To present proteomic pattern analysis as a sensitive predictive clinical tool.

Main Methods:

Quantitative measurement of thousands of proteins.
Proteomic pattern analysis using mass spectrometry.
Comparative analysis of proteins in complex biological systems like serum and tissues.

Related Experiment Videos

Main Results:

Proteomic pattern analysis relies on observed protein patterns, not discrete identification.
This technology allows for high-throughput analysis of hundreds of clinical samples daily.

Conclusions:

Proteomic pattern analysis is an effective method for early disease diagnosis.
This approach promises a novel, highly sensitive predictive clinical tool.
It aims to improve diagnostic and prognostic medicine.